| Literature DB >> 27894044 |
Srinivasulu Cherukupalli1, Rajshekhar Karpoormath2, Balakumar Chandrasekaran1, Girish A Hampannavar1, Neeta Thapliyal1, Venkata Narayana Palakollu1.
Abstract
Pyrazolo[1,5-a]pyrimidine scaffold is one of the privileged hetrocycles in drug discovery. Its application as a buliding block for developing drug-like candidates has displayed broad range of medicinal properties such as anticancer, CNS agents, anti-infectious, anti-inflammatory, CRF1 antagonists and radio diagnostics. The structure-activity relationship (SAR) studies have acquired greater attention amid medicinal chemists, and many of the lead compounds were derived for various disease targets. However, there is plenty of room for the medicinal chemists to further exploit this privileged scaffold in developing potential drug candidates. The present review briefly outlines relevant synthetic strategies employed for pyrazolo[1,5-a]pyrimidine derivatives. It also extensively reveals significant biological properties along with SAR studies. To the best of our understanding current review is the first attempt made towards the compilation of significant advances made on pyrazolo[1,5-a]pyrimidines reported since 1980s.Entities:
Keywords: Anti-cancer agents; Anti-infectious agents; Anti-inflammatory agents; CNS agents; Pyrazolo[1,5-a]pyrimidine; Radiopharmaceuticals
Mesh:
Substances:
Year: 2016 PMID: 27894044 DOI: 10.1016/j.ejmech.2016.11.019
Source DB: PubMed Journal: Eur J Med Chem ISSN: 0223-5234 Impact factor: 6.514